Skip to main content
. 2009 Aug 18;2(3):146–156. doi: 10.1593/tlo.09118

Table 1.

Pathological Details of Tissue (T) and Serum (S) Specimens and Summary of MS-PCR Results.

Sample T/S Tissue Type AJCC Stage AJCC TNM Classification Gleason Score Age (years) Race Tumor Content Specimen Source Specimen ID Gal3 MS-PCR GSTP1 MS-PCR
N-1 (T) Normal NA NA NA 66 White NA Ambion 0505-006 - -
N-2 (T) Normal NA NA NA 79 White NA Ambiom 0505-007-1 - -
N-3 (T) Normal NA NA NA 66 White NA Ambion 0505-007-2 - -
N-4 (T) Normal NA NA NA 59 White NA NDRI OD23155 - -
N-5 (T) Normal NA NA NA 73 U NA NDRI OD23791 - +
B-1 (T) BPH NA NA NA 78 U NA NDRI 83-1107 - -
B-2 (T) BPH NA NA NA U U NA NDRI 0056582-01 - -
I-1 (T) Tumor I T1 Nx Mx U 60 U U Collaborat 244850 + -
I-2 (T) Tumor I T1 Nx Mx 3 + 3 = 6 81 U U Collaborat 239521 + -
I-3 (T) Tumor I T1 Nx Mx 3 + 3 = 6 74 U U Collaborat 238708 + +
I-4 (T) Tumor I T1 Nx Mx 3 + 3 = 6 76 U U Collaborat 233011 + +
I-5 (T) Tumor I T1 Nx Mx 2 + 3 = 5 85 U U Collaborat 218496 + +
I-6 (T) Tumor I T1 Nx Mx 4 + 3 = 7 78 U U Collaborat 218163 + +
I-7 (T) Tumor I T1 Nx Mx 3 + 3 = 6 67 U U Collaborat 211841 + +
I-8 (T) Tumor I T1 Nx Mx 4 + 5 = 9 66 U U Collaborat 209668 + +
I-9 (T) Tumor I T1 Nx Mx 3 + 2 = 5 77 U U Collaborat 209667 + +
I-10 (T) Tumor I T1 Nx Mx 3 + 4 = 7 64 U U Collaborat 207087 + +
I-11 (T) Tumor I T1 Nx Mx 3 + 4 = 7 70 U U Collaborat 204782 + +
II-1 (T) Tumor II T2c Nx Mx 3 + 4 = 7 63 African 15% Ambion 0505-023 + +
II-2 (T) Tumor II T2c Nx Mx 3 + 4 = 7 69 White 20% CHTN MAD06-00234 + +
II-3 (T) Tumor II T2c Nx Mx 3 + 3 = 6 48 White 15% CHTN MAD06-00550 + +
II-4 (T) Tumor II T2c Nx Mx 3 + 4 = 7 61 White 10% CHTN MAD07-00014 + +
II-5 (T) Tumor II T2 Nx Mx 3 + 4 = 7 73 U 2–6% NDRI OD23791 + -
II-6 (T) Tumor II T2c Nx Mx 3 + 3 = 6 63 White 10% CHTN MAD06-00581 + +
II-7 (T) Tumor II T2c Nx Mx 3 + 3 = 6 50 African U CHTN MAD06-00504 + +
III-1 (T) Tumor III T3 N0 Mx 3 + 4 = 7 62 White U Ambion 0405-037 - +
III-2 (T) Tumor III T3b N0 Mx 4 + 3 = 7 48 White 90% CHTN MAD03-01617 + +
III-3 (T) Tumor III T3a Nx Mx 3 + 3 = 6 58 White 20% CHTN MAD05-00155 - +
III-4 (T) Tumor III T3a Nx Mx 4 + 3 = 7 66 White 10% CHTN MAD06-00118 - +
III-5 (T) Tumor III T3a Nx Mx 4 + 3 = 7 66 White 25% CHTN MAD06-00536 - +
III-6 (T) Tumor III T3a Nx Mx 3 + 3 = 6 44 White 30% CHTN MAD06-00681 - +
III-7 (T) Tumor III T3 Nx Mx 4 + 3 = 7 45 U U NDRI OD20866 - -
IV-1 (T) Tumor IV T3b N1 Mx 5 + 5 = 10 59 White 80% NDRI OD23155 - +
IV-2 (T) Tumor IV T3b N1 Mx U 66 U U CHTN MAD05-00059 - +
B-1 (S) BPH NA NA NA U U NA NDRI 0056582-02 - -
II-1 (S) Tumor II T2b N0 Mx 4 + 3 = 7 63 White U Asterand 55916A2 + +
II-2 (S) Tumor II T2c N0 Mx 3 + 3 = 6 U White U Asterand 47256A1 + +
III-1 (S) Tumor III T3a N0 Mx 3 + 4 = 7 66 White U Asterand 42629A1 - +
IV-1 (S) Tumor IV T3a N1 Mx 4 + 4 = 8 59 White U Asterand 53962A1 - +

Collaborat indicates collaborator (Dr. Francesco Cappello, University of Palermo, Italy); NA, not applicable; ND, not determined; Negl, negligible; U, unknown.